Chen Chen
Keine laufenden Positionen mehr
Profil
Chen Chen served as the Chief Executive Officer & Director at Sundia MediTech Co., Ltd.
from 2012 to 2015.
Prior to that, Dr. Chen worked as a Principal at Neurocrine Biosciences, Inc., Texas A&M University, and the University of Illinois.
Dr. Chen received an undergraduate degree from Xiamen University and a doctorate degree from Shanghai Institute of Organic Chemistry.
Ehemalige bekannte Positionen von Chen Chen
| Unternehmen | Position | Ende |
|---|---|---|
Sundia MediTech Co., Ltd.
 Sundia MediTech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China. | Vorstandsvorsitzender | 31.03.2015 |
| University of Illinois | Corporate Officer/Principal | - |
| Texas A&M University | Corporate Officer/Principal | - |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Ausbildung von Chen Chen
| Xiamen University | Undergraduate Degree |
| Shanghai Institute of Organic Chemistry | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sundia MediTech Co., Ltd.
Sundia MediTech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China. | Commercial Services |
